{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:25:06Z","timestamp":1761863106418},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T00:00:00Z","timestamp":1340582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T00:00:00Z","timestamp":1340582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,4,18]]},"DOI":"10.1038\/onc.2012.226","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T14:36:24Z","timestamp":1340634984000},"page":"2027-2036","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["PI3K regulation of the SKP-2\/p27 axis through mTORC2"],"prefix":"10.1038","volume":"32","author":[{"given":"K","family":"Shanmugasundaram","sequence":"first","affiliation":[]},{"given":"K","family":"Block","sequence":"additional","affiliation":[]},{"given":"B K","family":"Nayak","sequence":"additional","affiliation":[]},{"given":"C B","family":"Livi","sequence":"additional","affiliation":[]},{"given":"M A","family":"Venkatachalam","sequence":"additional","affiliation":[]},{"given":"S","family":"Sudarshan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,6,25]]},"reference":[{"key":"BFonc2012226_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc2347","volume":"8","author":"IM Chu","year":"2008","unstructured":"Chu IM, Hengst L, Slingerland JM . The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nature Rev Cancer 2008; 8: 253\u2013267.","journal-title":"Nature Rev Cancer"},{"key":"BFonc2012226_CR2","first-page":"217","volume":"23","author":"AG Anastasiadis","year":"2003","unstructured":"Anastasiadis AG, Calvo-Sanchez D, Franke KH, Ebert T, Heydthausen M, Schulz WA et al. p27KIP1-expression in human renal cell cancers: implications for clinical outcome. Anticancer Res 2003; 23: 217\u2013221.","journal-title":"Anticancer Res"},{"key":"BFonc2012226_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0090-4295(01)01188-8","volume":"58","author":"A Haitel","year":"2001","unstructured":"Haitel A, Wiener HG, Neudert B, Marberger M, Susani M . Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance. Urology 2001; 58: 477\u2013481.","journal-title":"Urology"},{"key":"BFonc2012226_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ijc.10763","volume":"102","author":"Y Hedberg","year":"2002","unstructured":"Hedberg Y, Davoodi E, Ljungberg B, Roos G, Landberg G . Cyclin E and p27 protein content in human renal cell carcinoma: clinical outcome and associations with cyclin D. Int J Cancer 2002; 102: 601\u2013607.","journal-title":"Int J Cancer"},{"key":"BFonc2012226_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/sj.bjc.6600922","volume":"88","author":"Y Hedberg","year":"2003","unstructured":"Hedberg Y, Ljungberg B, Roos G, Landberg G . Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray. Br J Cancer 2003; 88: 1417\u20131423.","journal-title":"Br J Cancer"},{"key":"BFonc2012226_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00428-004-1121-2","volume":"445","author":"C Langner","year":"2004","unstructured":"Langner C, von Wasielewski R, Ratschek M, Rehak P, Zigeuner R . Biological significance of p27 and Skp2 expression in renal cell carcinoma:a systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique. Virchows Arch 2004; 445: 631\u2013636.","journal-title":"Virchows Arch"},{"key":"BFonc2012226_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/cncr.10338","volume":"94","author":"T Migita","year":"2002","unstructured":"Migita T, Oda Y, Naito S, Tsuneyoshi M . Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 2002; 94: 973\u2013979.","journal-title":"Cancer"},{"key":"BFonc2012226_CR8","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/j.1349-7006.2010.01644.x","volume":"101","author":"A Sgambato","year":"2010","unstructured":"Sgambato A, Camerini A, Genovese G, De Luca F, Viacava P, Migaldi M et al. Loss of nuclear p27(kip1) and alpha-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma. Cancer Sci 2010; 101: 2080\u20132086.","journal-title":"Cancer Sci"},{"key":"BFonc2012226_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1158\/1078-0432.CCR-08-0170","volume":"15","author":"J Kim","year":"2009","unstructured":"Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S et al. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res 2009; 15: 81\u201390.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012226_CR10","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.4049\/jimmunol.168.10.5024","volume":"168","author":"M Stahl","year":"2002","unstructured":"Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM et al. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 2002; 168: 5024\u20135031.","journal-title":"J Immunol"},{"key":"BFonc2012226_CR11","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00018-008-8296-7","volume":"65","author":"J Vervoorts","year":"2008","unstructured":"Vervoorts J, Luscher B . Post-translational regulation of the tumor suppressor p27(KIP1). Cell Mol Life Sci 2008; 65: 3255\u20133264.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2012226_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0960-9822(99)80290-5","volume":"9","author":"LM Tsvetkov","year":"1999","unstructured":"Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H . p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9: 661\u2013664.","journal-title":"Curr Biol"},{"key":"BFonc2012226_CR13","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1101\/gad.11.11.1464","volume":"11","author":"RJ Sheaff","year":"1997","unstructured":"Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE . Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997; 11: 1464\u20131478.","journal-title":"Genes Dev"},{"key":"BFonc2012226_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/35095083","volume":"413","author":"NP Malek","year":"2001","unstructured":"Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM . A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 2001; 413: 323\u2013327.","journal-title":"Nature"},{"key":"BFonc2012226_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","volume":"7","author":"DR Alessi","year":"1997","unstructured":"Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 1997; 7: 261\u2013269.","journal-title":"Curr Biol"},{"key":"BFonc2012226_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1126\/science.277.5325.567","volume":"277","author":"D Stokoe","year":"1997","unstructured":"Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 1997; 277: 567\u2013570.","journal-title":"Science"},{"key":"BFonc2012226_CR17","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","volume":"16","author":"MA Frias","year":"2006","unstructured":"Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA et al. mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 2006; 16: 1865\u20131870.","journal-title":"Curr Biol"},{"key":"BFonc2012226_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","volume":"11","author":"DA Guertin","year":"2006","unstructured":"Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 2006; 11: 859\u2013871.","journal-title":"Dev Cell"},{"key":"BFonc2012226_CR19","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1101\/gad.1461206","volume":"20","author":"Q Yang","year":"2006","unstructured":"Yang Q, Inoki K, Ikenoue T, Guan KL . Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev 2006; 20: 2820\u20132832.","journal-title":"Genes Dev"},{"key":"BFonc2012226_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.devcel.2006.08.013","volume":"11","author":"C Shiota","year":"2006","unstructured":"Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA . Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev Cell 2006; 11: 583\u2013589.","journal-title":"Dev Cell"},{"key":"BFonc2012226_CR21","doi-asserted-by":"publisher","first-page":"10998","DOI":"10.1074\/jbc.M110.195016","volume":"286","author":"X Gan","year":"2011","unstructured":"Gan X, Wang J, Su B, Wu D . Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 2011; 286: 10998\u201311002.","journal-title":"J Biol Chem"},{"key":"BFonc2012226_CR22","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1074\/jbc.M110.166991","volume":"286","author":"I Tato","year":"2011","unstructured":"Tato I, Bartrons R, Ventura F, Rosa JL . Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K\/Akt signaling. J Biol Chem 2011; 286: 6128\u20136142.","journal-title":"J Biol Chem"},{"key":"BFonc2012226_CR23","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1038\/onc.2011.22","volume":"30","author":"EK Kim","year":"2011","unstructured":"Kim EK, Yun SJ, Ha JM, Kim YW, Jin IH, Yun J et al. Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis. Oncogene 2011; 30: 2954\u20132963.","journal-title":"Oncogene"},{"key":"BFonc2012226_CR24","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1128\/MCB.00289-08","volume":"28","author":"J Huang","year":"2008","unstructured":"Huang J, Dibble CC, Matsuzaki M, Manning BD . The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 2008; 28: 4104\u20134115.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012226_CR25","doi-asserted-by":"publisher","first-page":"34495","DOI":"10.1074\/jbc.C800170200","volume":"283","author":"A Toschi","year":"2008","unstructured":"Toschi A, Lee E, Gadir N, Ohh M, Foster DA . Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem 2008; 283: 34495\u201334499.","journal-title":"J Biol Chem"},{"key":"BFonc2012226_CR26","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1158\/0008-5472.CAN-07-5869","volume":"68","author":"PC McDonald","year":"2008","unstructured":"McDonald PC, Oloumi A, Mills J, Dobreva I, Maidan M, Gray V et al. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 2008; 68: 1618\u20131624.","journal-title":"Cancer Res"},{"key":"BFonc2012226_CR27","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Kang SA, Chang JW, Liu Q, Zhang J, Gao Y et al. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 2009; 284: 8023\u20138032.","journal-title":"J Biol Chem"},{"key":"BFonc2012226_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1756-9966-27-51","volume":"27","author":"Z Liu","year":"2008","unstructured":"Liu Z, Fu Q, Lv J, Wang F, Ding K . Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. J Exp Clin Cancer Res 2008; 27: 51.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFonc2012226_CR29","doi-asserted-by":"publisher","first-page":"16201","DOI":"10.1074\/jbc.M100873200","volume":"276","author":"K Saito","year":"2001","unstructured":"Saito K, Scharenberg AM, Kinet JP . Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk. J Biol Chem 2001; 276: 16201\u201316206.","journal-title":"J Biol Chem"},{"key":"BFonc2012226_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/ncb1849","volume":"11","author":"HK Lin","year":"2009","unstructured":"Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, Chan CH et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt\/PKB. Nat Cell Biol 2009; 11: 420\u2013432.","journal-title":"Nat Cell Biol"},{"key":"BFonc2012226_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ncb1847","volume":"11","author":"D Gao","year":"2009","unstructured":"Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, Wei W . Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 2009; 11: 397\u2013408.","journal-title":"Nat Cell Biol"},{"key":"BFonc2012226_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4161\/cc.9.5.10914","volume":"9","author":"T Bashir","year":"2010","unstructured":"Bashir T, Pagan JK, Busino L, Pagano M . Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization. Cell Cycle 2010; 9: 971\u2013974.","journal-title":"Cell Cycle"},{"key":"BFonc2012226_CR33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.4161\/cc.9.5.10915","volume":"9","author":"C Boutonnet","year":"2010","unstructured":"Boutonnet C, Tanguay PL, Julien C, Rodier G, Coulombe P, Meloche S . Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2. Cell Cycle 2010; 9: 975\u2013979.","journal-title":"Cell Cycle"},{"key":"BFonc2012226_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.4161\/cc.9.5.10916","volume":"9","author":"H Wang","year":"2010","unstructured":"Wang H, Cui J, Bauzon F, Zhu L . A comparison between Skp2 and FOXO1 for their cytoplasmic localization by Akt1. Cell Cycle 2010; 9: 1021\u20131022.","journal-title":"Cell Cycle"},{"key":"BFonc2012226_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/emboj.2011.478","volume":"31","author":"V Nogueira","year":"2012","unstructured":"Nogueira V, Sundararajan D, Kwan JM, Peng XD, Sarvepalli N, Sonenberg N et al. Akt-dependent Skp2 mRNA translation is required for exiting contact inhibition, oncogenesis, and adipogenesis. EMBO J 2012; 31: 1134\u20131146.","journal-title":"EMBO J"},{"key":"BFonc2012226_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ccr.2008.12.017","volume":"15","author":"DA Guertin","year":"2009","unstructured":"Guertin DA, Stevens DM, Saitoh M, Kinkel S, Crosby K, Sheen JH et al. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 2009; 15: 148\u2013159.","journal-title":"Cancer Cell"},{"key":"BFonc2012226_CR37","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","volume":"71","author":"P Gulhati","year":"2011","unstructured":"Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 2011; 71: 3246\u20133256.","journal-title":"Cancer Res"},{"key":"BFonc2012226_CR38","doi-asserted-by":"publisher","first-page":"11712","DOI":"10.1158\/0008-5472.CAN-07-2223","volume":"67","author":"J Masri","year":"2007","unstructured":"Masri J, Bernath A, Martin J, Jo OD, Vartanian R, Funk A et al. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res 2007; 67: 11712\u201311720.","journal-title":"Cancer Res"},{"key":"BFonc2012226_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/BJ20081668","volume":"416","author":"JM Garcia-Martinez","year":"2008","unstructured":"Garcia-Martinez JM, Alessi DR . mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 2008; 416: 375\u2013385.","journal-title":"Biochem J"},{"key":"BFonc2012226_CR40","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-09-3022","volume":"16","author":"DC Cho","year":"2010","unstructured":"Cho DC, Cohen MB, Panka DJ, Collins M, Ghebremichael M, Atkins MB et al. The efficacy of the novel dual PI3-kinase\/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma. Clin Cancer Res 2010; 16: 3628\u20133638.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012226_CR41","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/MCB.00483-09","volume":"29","author":"S Sudarshan","year":"2009","unstructured":"Sudarshan S, Sourbier C, Kong HS, Block K, Valera Romero VA, Yang Y et al. Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol 2009; 29: 4080\u20134090.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012226_CR42","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM . Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science 2005; 307: 1098\u20131101.","journal-title":"Science"},{"key":"BFonc2012226_CR43","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-09-0975","volume":"69","author":"J Huang","year":"2009","unstructured":"Huang J, Wu S, Wu CL, Manning BD . Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res 2009; 69: 6107\u20136114.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012226","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:29:49Z","timestamp":1647887389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,25]]},"references-count":43,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2013,4,18]]}},"alternative-id":["BFonc2012226"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.226","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,25]]},"assertion":[{"value":"5 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}